How Ro uses a $1,000 price anchor to sell a GLP-1 pill | Fluid
Esc

How Ro uses a $1,000 price anchor to sell a GLP-1 pill

A 29-second vertical video. A tiny pill sits on a blue dish on a side table beside keys and flowers, with Serena Williams inset. The voiceover asks why you'd pay a thousand a month, claims the new pill matches the shot's results for less, and cites a 14% average weight-loss figure. The click lands on Ro's quiz.

Ro
71 creatives lead here1 / 71
Ro · Serena-led weight-loss quiz

Public page captured October 22, 2026. Promotional sheets and temporary interface overlays were dismissed or removed in the static reference. No personal or medical information was entered. Captured entry screens do not reproduce the complete consultation.

Ro: full page screenshot

Join Serena on Ro

Visual reference: Why pay more? · bag-and-product story. The main campaign sends price, medication-launch, creator and celebrity ads to one Serena-led entrance. A treatment-format question sits in the hero; choosing Learn about both reveals a weight-goal question without leaving the page. Compare the creative with the destination and explore the other ads sharing this route.

Brand
Ro
Observed offer
Online GLP-1 assessment; medication and membership terms apply
Creative angle
Creator stories
Page type
Quiz entry
Ad format
Video · 0:29
Listed start date
Jul 14, 2026
Captured
Oct 22, 2026
Library ID
894314813137605
Destination
ro.co

Selected for its design and offer structure. Ad performance isn’t available in this collection.

What this ad does well

The opening caption, "Why pay more for GLP-1s?", is backed by a specific anchor in the voiceover: a thousand a month. That number gives the viewer something concrete to compare against. The visual is a smart contrast, too: one tiny pill on a dish next to everyday things like keys and hand cream, followed by boxes of injectable pens, so the pill reads as the smaller, simpler option. The weight-loss figure arrives as an on-screen claim with its footnote (14% on average in a year versus 3.1% with diet and exercise alone, based on a study, results may vary).

What's missing

The ad gives you the high number and never the low one, so the viewer knows what they'd be escaping but not what they'd pay on Ro. Serena stays in the inset without speaking to her own experience, so the ad uses her face more than her story. If you anchor against an expensive alternative, put your own price right after it; the comparison only feels real when both numbers are on screen.

Beat by beat

  1. 0-4s
    A tiny pill on a blue dish on a wooden table, with keys, flowers and hand cream nearby, under the caption asking why pay more, with Serena inset.

    It pairs a price question with a picture of how small the alternative is.

  2. 4-10s
    The voiceover cites paying a thousand a month and says the new FDA-approved pill is on Ro at the lowest cost when paying cash.

    It sets a high price anchor so the pill looks like the better deal.

  3. 10-20s
    Boxes of injectable Wegovy pens appear as the voiceover claims comparable weight loss to the shot at a lower price.

    It shows the familiar option the pill is being compared against.

  4. 20-29s
    A caption claims 14% average weight loss in a year, with the study footnote, and says it's the first pill approved for weight management.

    It adds a specific claim and a first-of-its-kind reason to look now.

The offer

No Ro price is stated. The voiceover anchors against paying a thousand a month and claims Ro has the lowest cost for the pill when paying cash.

Where it sends people

The ad sends people to Ro's weight-loss quiz entry, the destination for 71 of the 100 Ro ads in the Fluid library. A quiz sits on the strongest rung of the landing-page ladder, and this one starts fast: the page opens on "Lose weight on Ro," a banner claiming "The lowest prices for GLP-1s are on Ro," a photo of Serena Williams labeled as a Ro member, and a card asking "Which Ro option are you interested in?" with GLP-1 pill, GLP-1 shot, both, or a provider recommendation as the answers. The page carries Serena over from the inset and lists GLP-1 pill as the first answer, so the click feels continuous. The ad's thousand-a-month anchor sets up a price reveal that the entry screen doesn't deliver, which leaves the viewer holding the question the ad raised. Showing a starting price under the banner would pay off the anchor.

The page it sends people to: How Ro turns its Serena Williams ads into a one-question start

Ro's main weight-loss landing page is a quiz entry: Serena Williams, labeled as a Ro member, stands beside a card asking which GLP-1 option you want. It's the destination for 71 Ro ads in the Fluid library, mostly price-led statics, Serena creator videos and pill-versus-pen product stills, nearly all ending on See if you qualify.

How the page is built

  1. 01
    Announcement bar

    A pale yellow strip claims the lowest prices for GLP-1s are on Ro, the page's only answer to 'is this affordable?'

  2. 02
    Headline

    Lose weight on Ro names the category and the brand, so the visitor knows they're in the right place before reading anything else.

  3. 03
    Serena Williams photo

    Serena holds a pen-style product with a Ro member label and a product thumbnail beside her, answering 'is this the thing from the ad?'

  4. 04
    Treatment-format question

    A white card asks which Ro option you're interested in (pill, shot, learn about both, or a provider recommendation), which starts the quiz and sorts visitors by how far along they are.

  5. 05
    Weight-goal question

    After Learn about both, the same card asks how much weight you're looking to lose in ranges plus Not sure yet, keeping the visitor on the page while the quiz continues.

  6. 06
    Footer

    Legal, terms, privacy and consumer health data privacy links sit beside a LegitScript Certified badge, answering 'is this a legitimate pharmacy?' for anyone who scrolls.

The first fixes we would make

  1. Many of the ads sending traffic here lead with price (Half the price, Affordable GLP-1, Same results, more savings), and the page answers with one general claim in the announcement bar. Put a starting price under each format option, using the same number the ad showed, so the person who clicked for the price sees it before they answer.
  2. The format question asks people to choose between a pill and a shot with nothing beside either option. Add a short line under each choice that describes it the way the product-choice ads already do, so someone arriving from a Pill or pen ad can pick without leaving to research.

Read the full breakdown of this page

Three hooks you could test

  • Call out the habit you're replacing. “Still paying the premium price for the version everyone started with?”
  • Turn the benefit into a picture people get in a second. “Next to your keys, it's the smallest thing on the table.”
  • Sell the outcome. “Same routine you wanted, without the monthly bill you dreaded.”

What to borrow for your brand

  • Anchor against the expensive alternative your buyer already knows, then show your own price immediately after.
  • Stage your product next to everyday objects so its size and simplicity read without a caption.
  • Cut from your product to the option it replaces so the comparison is visual, not just spoken.

Transcript

Why pay a 1000 a month to start losing weight with GOP ones? The new GOP1 pill has comparable weight loss to the shot at an even lower price. It's true you can lose 14% of your body weight with the new GLP1 pill. It's the 1st one that's FA approved for weight management, and it's on the road.
Text on screen
  • Why pay more for GLP-1s?
  • PROT
  • OTEC
  • a thousand a month
  • PROTI
  • OTECTED
  • The new FDA-approved
  • GLP-1 pill is on Ro at the
  • lowest cost around
  • (when paying cash)
  • PRO
  • The new GLP-1 pill
  • FECTED
  • PRON
  • TED
  • -02-28
  • when paving 34@13735-01
  • CECTED
  • NDC 0169-4524-01
  • (semaglutide) injectior
  • 2,4 mg/0.75 mL
  • (semaglutide) injecti
  • 2.4 mg/0.75 ml
  • weight loss to the shot
  • (semaglutide) injec
  • LATED
  • LOT:
  • ° 0169-4524-03
  • serian paying un
  • LIN 452401
  • NOC 016> 4524-01
  • 2.4 mg
  • (semaglutide) injection EC VEL
  • For subcutaneous
  • 2.4 mg/0.75 mL.
  • List: 452401
  • (semaglutide) injection
  • For suhcutaneous
  • catap even lower price,
  • (semáglutide) injection

One of 100 Ro ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.